Updated August 9, 2026

Duloxetine Shortage 2026: Is Cymbalta Hard to Find?

Evan Brown
Written by Evan Brown
Prescription Savings Researcher
Dr. Megan Harris, MD Medically Reviewed by Dr. Megan Harris, MD
Verified August 10, 2026: We checked the FDA Drug Shortages Database, FDA Enforcement Reports, and manufacturer recall notices. No new recalls were issued in July or August 2026. The Asclemed USA recall (lots 050725G-30 and 050725F-30) remains the most recent classification.
Quick Answer

Duloxetine is not listed on the FDA's Drug Shortages Database as of August 2026, and standard delayed-release capsules aren't on the ASHP list either. If your pharmacy is out, the more likely explanation is a manufacturer recall, not a true nationwide shortage. Starting in October 2024, the FDA has processed a string of recalls on specific duloxetine lots after routine testing turned up N-nitroso-duloxetine, a nitrosamine impurity, above the agency's recommended limit. The most recent rounds pulled bottles distributed under the Breckenridge Pharmaceutical and Quallent Pharmaceuticals Health labels, both sourced from capsules made by Towa Pharmaceutical Europe in Spain. Dozens of other generic manufacturers aren't touched by these recalls, which is why a different pharmacy, or a different brand of the same generic, usually solves the problem same day.

The one formulation that had a real, ASHP-listed shortage is Drizalma Sprinkle, the sprinkle-capsule version made by Sun Pharma for patients who can't swallow pills. That gap ran from 2022 into mid-2024 and has since stabilized.

August 10, 2026 Update: No new duloxetine recalls in July or August. The most recent FDA recall was classified June 2, 2026 (Asclemed USA). Standard duloxetine capsules remain off the FDA shortage list. See all recalled lot numbers →

Key Takeaways

  • Standard duloxetine capsules (20, 30, 40, and 60 mg) are not on the FDA or ASHP shortage list as of August 2026.
  • Four separate nitrosamine recalls have hit duloxetine since October 2024, most recently in June 2026, all tied to N-nitroso-duloxetine found above the FDA's limit.
  • Every recalled lot traces back to capsules made by Towa Pharmaceutical Europe and sold under the Breckenridge Pharmaceutical or Quallent Pharmaceuticals Health labels — other manufacturers aren't part of these recalls.
  • Drizalma Sprinkle's real shortage (2022–mid-2024) is over. Sun Pharma has supplied it consistently since production resumed.
  • Generic duloxetine runs $30 to $230 a month without insurance; a free discount card usually gets it under $20.
  • Stopping duloxetine cold can cause real withdrawal-like symptoms, so a bridge plan with your prescriber matters more than waiting it out.

If your pharmacist has told you they're "out of duloxetine" twice in the last year, you're not imagining a pattern. But the word "shortage" doesn't quite fit what's happening. What's actually going on is a run of manufacturer recalls tied to one specific impurity, layered on top of a drug that gets prescribed to millions of people for depression, anxiety, nerve pain, and fibromyalgia. Here's what's true, what isn't, and what actually works if you're standing at the counter with an empty bottle.

0
Formal FDA or ASHP shortage listings for standard duloxetine capsules
4
Nitrosamine recalls on duloxetine lots since October 2024
$20
Typical monthly cost with a free discount card

1. Is Duloxetine Officially in a Shortage?

Technically, no. Check the FDA's Drug Shortages Database or the ASHP Drug Shortage Resource Center today and you won't find standard duloxetine delayed-release capsules on either list. That matters for how insurers and pharmacies process the situation on paper, but it doesn't explain why your specific pharmacy handed you an empty bag.

What's actually happening: since late 2024, the FDA has repeatedly flagged duloxetine lots for containing N-nitroso-duloxetine, a nitrosamine byproduct that can form during manufacturing, at levels above the agency's recommended limit. Each recall is voluntary, initiated by the distributor, and limited to specific lot numbers, not the entire drug supply. Nitrosamines are considered probable carcinogens with long-term exposure, and the FDA has been clear that the immediate health risk from any single affected bottle is low. Patients are told not to stop taking duloxetine over a recall without talking to a prescriber first.

So the honest version is this: duloxetine as a molecule is not scarce. Dozens of generic manufacturers make it. What keeps happening is that specific labelers, mainly Breckenridge Pharmaceutical and Quallent Pharmaceuticals Health, both distributing capsules manufactured by Towa Pharmaceutical Europe in Spain, keep getting hit with the same impurity issue. If your regular pharmacy leaned heavily on one of those suppliers, you feel a shortage even though one doesn't officially exist.

2. Why You're Still Running Into Empty Shelves

Three things are stacking on top of each other here.

First, duloxetine is genuinely one of the most-prescribed medications in the country. It covers major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathy, fibromyalgia, and chronic musculoskeletal pain, so a huge and varied patient population relies on it.

Second, nitrosamine testing across the generic drug industry got much stricter after the valsartan contamination cases a few years back, and manufacturers making older, complex molecules like duloxetine have kept turning up trace impurities during routine batch testing.

Third, a single pharmacy or small chain often buys the bulk of its stock from one or two wholesalers. When a recall hits that wholesaler's supplier, the shelf goes empty locally even though a pharmacy three miles away, stocked by a different distributor, never noticed a thing.

Put together, you get a drug that is not in a national shortage but produces a very real, very local experience of "they don't have it" over and over again.

3. Timeline: Recalls and Recovery, 2013–2026

How duloxetine's supply picture developed
DateEvent
2013Generic duloxetine launches after the Cymbalta patent expires, quickly becoming a low-cost standard
2020FDA approves Drizalma Sprinkle, a sprinkle-capsule version made by Sun Pharma for patients who can't swallow pills
2022–2024Sun Pharma manufacturing disruptions cause a genuine, ASHP-listed Drizalma Sprinkle shortage
October 2024First nitrosamine recall: Towa Pharmaceutical Europe capsules distributed by Breckenridge Pharmaceutical, roughly 7,100 bottles of 20 mg capsules
December 2024Second, broader recall covering additional strengths and lots shipped between March 2023 and August 2024
Mid-2024Sun Pharma resumes full Drizalma Sprinkle production; ASHP listing improves
November 2025Third recall: Quallent Pharmaceuticals Health, distributing Towa-manufactured 60 mg capsules under the Breckenridge label, classified Class II by the FDA in December 2025
June 2026Fourth recall: Breckenridge Pharmaceutical pulls a 30 mg lot for the same nitrosamine issue
August 2026Standard duloxetine capsules remain off the FDA and ASHP shortage lists; Drizalma Sprinkle supply is stable

4. Current Availability by Product

Duloxetine product availability, current status
ProductManufacturerStatus
Generic duloxetine DR capsules (most manufacturers)Multiple, 15+ generic makersWidely available
Duloxetine 60 mg, 1000-ct bottlesQuallent / Breckenridge (mfg. Towa)Specific lots recalled; other bottles of the same strength unaffected
Duloxetine 30 mg, various lotsBreckenridge (mfg. Towa)Lot 241180C recalled June 2026; other manufacturers' 30 mg unaffected
Drizalma Sprinkle (20/30/40/60 mg)Sun PharmaAvailable; stable since 2024
Brand-name CymbaltaEli LillyAvailable, rarely dispensed since generics exist

Notice the pattern: it's not duloxetine that's scarce, it's specific bottles from specific labelers. A pharmacist who checks their wholesaler catalog can almost always find a strength from a manufacturer that hasn't been touched by a recall.

Cymbalta Recall 2026: Latest Lot Numbers

While brand-name Cymbalta (Eli Lilly) has not been recalled, multiple generic duloxetine manufacturers have faced recalls since October 2024. Here are the lot numbers to check on your bottle as of August 2026:

Recalled duloxetine lots — check your bottle
ManufacturerLot NumberStrengthExpiration
Asclemed USA050725G-30, 050725F-3030 mgJun 30, 2026
Breckenridge (Towa)241180C30 mgApr 2027
Quallent / Breckenridge (Towa)240947C, 240962C, 240534C, 240977C60 mgVarious 2025–2026
Rising HealthMultiple lots (DT6023059A, DT6023060A, etc.)60 mgNov 2024 – Dec 2025

How to Check If Your Duloxetine Bottle Is Recalled

  1. Find your lot number on the bottle label — usually near the expiration date.
  2. Compare against the table above. If your lot matches, don't panic. The FDA classifies these as Class II recalls, meaning the risk of serious harm is remote.
  3. Call your pharmacy to confirm whether your specific bottle is affected. Some lots were distributed only to specific wholesalers.
  4. Don't stop taking duloxetine without talking to your prescriber. The FDA advises against abrupt discontinuation.

Duloxetine Recall 2026: Check Your Lot Number

Nitrosamine-related duloxetine recalls, October 2024–June 2026
DateCompanyProduct / LotReason
Oct 10, 2024Breckenridge Pharmaceutical (mfg. Towa)20 mg, Lot 220128, 500-ct bottlesN-nitroso-duloxetine above FDA limit
Dec 2024Rising Health LLC20/30/60 mg, lots shipped Mar 2023–Aug 2024N-nitroso-duloxetine above interim limit
Nov 21, 2025Quallent Pharmaceuticals Health / Breckenridge (mfg. Towa)60 mg, 1000-ct, lots 240947C, 240962C, 240534C, 240977CN-nitroso-duloxetine above FDA limit; Class II, Dec 3, 2025
Jun 2026Breckenridge Pharmaceutical30 mg, Lot 241180C, exp. April 2027N-nitroso-duloxetine above FDA limit

All four recalls were voluntary, all four were classified Class II by the FDA, meaning the risk of serious harm is low, and none have been linked to reported adverse events. If your bottle's NDC or lot number matches one of these, don't stop taking it on your own. Call your pharmacist to confirm, and ask your prescriber whether a short bridge supply makes sense while you swap to an unaffected lot.

6. Alternatives If Duloxetine Isn't Available

Before reaching for a different drug entirely, ask your pharmacist to check other manufacturers of duloxetine first, since that solves most cases without any prescription change. If duloxetine genuinely isn't obtainable in time, these are the SNRIs prescribers most often consider instead.

Duloxetine alternatives at a glance
AlternativeBest fitKey consideration
Venlafaxine (Effexor XR)Depression, GAD, panic disorder, social anxietyBroadest range of indications; not FDA-approved for pain
Desvenlafaxine (Pristiq)Depression, patients needing simpler once-daily dosingFewer drug interactions; a reasonable option with liver concerns
Milnacipran (Savella)Fibromyalgia specificallyFDA-approved for fibromyalgia; requires twice-daily dosing
Levomilnacipran (Fetzima)Major depressive disorderMost norepinephrine-selective SNRI; approved for MDD only

Switching temporarily makes sense when...

  • You're within a day or two of running out with no unaffected duloxetine bottle in reach
  • Your prescriber agrees the alternative covers your specific diagnosis
  • You can get a follow-up appointment once duloxetine is back in stock

It's worth avoiding when...

  • You're being treated for nerve pain or musculoskeletal pain and the alternative isn't approved for that use
  • You have supply for another week, since a manufacturer switch will likely resolve it without changing drugs at all
  • You haven't confirmed insurance coverage for the new medication yet

7. Switching Antidepressants Safely

Never switch SNRIs on your own. Duloxetine has a short half-life, and stopping it abruptly, even for a few days, can trigger discontinuation symptoms: dizziness, nausea, irritability, and the sensation many patients describe as brain zaps. This risk is higher at higher doses and after longer-term use. A prescriber can arrange a short overlap or taper if a switch is genuinely necessary, which is far gentler than an unplanned gap.

For example, a patient on 60 mg duloxetine for fibromyalgia who can't locate any bottle for a week is a very different case than a patient on 30 mg for mild anxiety who has a week's cushion left. The first case usually needs a same-week call to the prescriber's office. The second case usually resolves with a phone call to two more pharmacies.

8. Step-by-Step: What to Do If Your Pharmacy Is Out

1

Ask exactly which manufacturer they're missing

Pharmacists can usually tell you if it's a specific labeler's stock that's out, not duloxetine as a whole. That single question often ends the search right there.

2

Call two or three nearby pharmacies before assuming it's everywhere

Independent pharmacies in particular often source from a wholesaler untouched by whichever recall is active that month.

3

Ask about a partial fill

If a pharmacy has a few days' worth on hand but not a full 30-day supply, ask for a partial fill now and the rest once new stock arrives.

4

Loop in your prescriber once you're down to a few days

Don't wait until the bottle is empty. A quick call gives your prescriber time to send an e-prescription to a pharmacy with confirmed stock or arrange a short bridge supply.

5

Don't stop cold if you truly can't get any

If every option has failed and you're out, tell your prescriber that day. A short, supervised taper or temporary alternative is much safer than going without.

9. What Duloxetine Actually Costs in 2026

Generic duloxetine is one of the more affordable antidepressants on the market, though price still swings a lot by pharmacy.

  • Generic duloxetine, no insurance, no coupon: roughly $30 to $230 for a 30-day supply, depending on strength, quantity, and pharmacy.
  • With a free discount card from a service compared in our Inside Rx vs SingleCare comparison: typically under $20 at most major chains.
  • Brand-name Cymbalta: often $285 to $470 a month, and rarely covered by insurance since a generic exists.
  • Mail-order and low-cost pharmacies: some patients find lower, more stable pricing through mail-order options, which is worth comparing using a drug price checker before committing to one pharmacy.

Price comparison matters here specifically because it isn't fixed. Two pharmacies three blocks apart can differ by $100 or more for the exact same generic bottle, so checking before you fill is worth the two minutes it takes.

10. Comparing Cost-Help Options

Because generic duloxetine is already inexpensive, most patients don't need a formal patient assistance program. Where things get confusing is knowing which option actually applies to your situation. Here's how the main ones stack up.

Eligibility Comparison

Who qualifies for each type of cost-help option
OptionWho qualifies
Free discount cards (GoodRx, Inside Rx, SingleCare)Anyone, insured or not — no application or income proof required
Lilly Cares FoundationUninsured or underinsured patients prescribed brand-name Cymbalta specifically, within income limits
NeedyMeds / Rx OutreachIncome-eligible patients, generic and brand medications, varies by program
State Pharmaceutical Assistance ProgramsVaries by state; often seniors, disabled residents, or low-income adults
Medicare Extra Help (Low-Income Subsidy)Medicare Part D enrollees who meet income and asset limits

Income Limit Comparison

How income requirements generally compare
OptionGeneral income guideline
Discount cardsNo income limit
Lilly Cares FoundationTypically set as a multiple of the federal poverty level; check Lilly Cares directly for the current threshold
NeedyMeds programsVaries widely by program; searchable at NeedyMeds
Medicare Extra HelpUpdated annually by the Social Security Administration; confirm current limits at Medicare.gov before assuming you don't qualify

Covered Medications Comparison

What each program actually covers
OptionCovers generic duloxetine?Covers brand Cymbalta?
Discount cardsYesRarely needed since generic is cheaper
Lilly Cares FoundationNoYes
NeedyMeds / Rx OutreachYes, on many program listingsSometimes
Medicare Extra HelpYesYes

Application, Approval, and Renewal

What to expect if you apply
OptionHow to applyTypical approval timeRenewal
Discount cardsShow a code or app at the register — no applicationInstantNone needed
Lilly Cares FoundationPrescriber and patient complete a joint application with income documentation2 to 4 weeksAnnual reapplication
NeedyMeds programsVaries; many require a short online form and proof of income1 to 3 weeksVaries by program
Medicare Extra HelpApply through the Social Security Administration or Medicare.gov4 to 6 weeksAnnual review; some beneficiaries are auto-renewed

Common Mistakes to Avoid

  • Assuming a discount card requires signing up first. Most work the moment you show the code at checkout, with no account needed.
  • Assuming Lilly Cares covers your generic bottle. Brand-manufacturer programs almost always cover the brand product only, not the generic version pharmacies dispense by default.
  • Using the same discount card everywhere out of habit. Prices differ by pharmacy and change often, so comparing before every fill can save real money.
  • Waiting until the pharmacy counter to ask about help. Calling ahead gives a pharmacist time to check other manufacturers or apply a coupon before you're standing there.
  • Letting a patient assistance renewal lapse. Missing an annual renewal deadline can create an unexpected coverage gap right when you need it least.

11. Decision Tree: What Should You Do Right Now?

Is your pharmacy currently out of your usual duloxetine bottle?
No — fill as normal, no action needed.
Yes — continue below.
Can your pharmacist order the same strength from a different manufacturer?
Yes — ask for that swap; no prescription change is usually needed.
No, or not in time — continue below.
Do you have at least 3 to 5 days of supply left?
Yes — call two or three nearby pharmacies while you wait.
No, running low — continue below.
Result: Contact your prescriber the same day

Ask about a bridge supply or a short-term alternative rather than stopping duloxetine without a plan.

Related: Adderall Shortage 2026: Pharmacy Availability & Alternatives

Another commonly prescribed medication with a similar pattern of local stockouts driven by supplier-specific issues rather than a true national shortage.

Frequently Asked Questions

No. Standard duloxetine delayed-release capsules are not listed on the FDA's Drug Shortages Database or the ASHP Drug Shortage Resource Center as of August 2026. Local stockouts are usually tied to a specific recalled lot or a single distributor running low, not a nationwide supply problem.

Since October 2024, the FDA has processed a series of Class II recalls on duloxetine lots after testing found N-nitroso-duloxetine, a nitrosamine impurity, above the agency's recommended limit. Most of the recalled capsules were manufactured by Towa Pharmaceutical Europe and distributed under the Breckenridge Pharmaceutical and Quallent Pharmaceuticals Health labels. A pharmacy that ordered heavily from one of these suppliers can end up with an empty shelf even though duloxetine as a whole is not scarce.

Not currently. Drizalma Sprinkle, the sprinkle-capsule version of duloxetine made by Sun Pharma, had a genuine ASHP-listed shortage from 2022 through mid-2024 tied to manufacturing disruptions. Sun Pharma resumed full production in 2024, and the formulation has remained generally available through 2026.

Ask your pharmacist whether they can order the same strength from a different manufacturer, since most recalls affect only specific labelers, not duloxetine as a drug. If that fails, call one or two nearby pharmacies before assuming it's unavailable everywhere, and contact your prescriber if you're within a few days of running out.

Generally yes. Generic duloxetine from any FDA-approved manufacturer contains the same active ingredient at the same strength and is considered therapeutically equivalent. Some patients notice a difference in inactive ingredients or capsule coating, but a manufacturer switch does not require a new prescription in most cases. Ask your pharmacist if you have concerns about a specific switch.

Stopping duloxetine abruptly can cause discontinuation symptoms, including dizziness, nausea, irritability, and sensations often described as brain zaps. This is more likely at higher doses or after longer use. Contact your prescriber before your supply runs out so they can arrange a bridge fill, a short-term alternative, or a taper plan rather than an unplanned stop.

Lilly Cares, Eli Lilly's patient assistance foundation, generally covers brand-name Cymbalta for eligible uninsured or underinsured patients, not the generic. Since generic duloxetine already costs far less than the brand, most patients save more with a free discount card than by applying to a brand-specific assistance program.

Generic duloxetine typically runs $30 to $230 for a 30-day supply depending on the pharmacy, strength, and quantity, before any coupon. A free discount card from a service like GoodRx or Inside Rx usually brings that down to under $20 at most retail chains.

Other Drug Shortages in 2026

Disclaimer: This guide is for general educational purposes and reflects publicly reported duloxetine supply and recall information as of August 9, 2026. It does not constitute medical advice. Recall status and pharmacy stock can change quickly and vary by location — confirm current availability with your specific pharmacy, and never change your medication, dose, or schedule without first talking to your prescriber. If you are unable to obtain your medication and are at risk of running out, contact your prescriber's office or pharmacist immediately. If you're experiencing a mental health crisis, the 988 Suicide & Crisis Lifeline is available 24/7 by calling or texting 988.

Evan Brown
About the Author
Evan Brown — Medical Content Researcher

Evan Brown is a medical content researcher who specializes in translating confusing prescription pricing and supply mechanics into practical guidance patients can actually use before they pay.

View Full Profile →
Dr. Megan Harris, MD
Medical Review
Dr. Megan Harris, MD

Dr. Megan Harris, MD reviews health content for accuracy, checking recall details, dosing information, and pharmacy network claims against current sources.

View Full Profile →

Contact Refill Relay